About The Workshop
There is an increasing demand from clients seeking therapeutic support in their personal use of psychedelics. However, many clinicians interested in psychedelic preparation and integration are unsure as to how to provide these services as psychedelics mostly remain illegal. In this workshop, we will outline legal and ethical frameworks relevant to providing therapy to clients around their personal use of psychedelics, as well as describe how harm reduction approaches are suitable for this developing clinical area. We will review the most common ethical and legal risks for therapists engaging in this work and steps to mitigate these risks. This workshop will also describe some of the benefits and rewards that are involved in offering this type of therapy to clients, as well as some of the challenges.
Finally, we will discuss common decision points, provide reflection questions for clinicians considering involvement in psychedelic integration therapy, and suggest next steps for further training and education. Workshop participants will also be able to practice with newly learned ideas and methods using a case example. This workshop is based on extensive research and writing we have conducted into the legal and ethical issues of working with psychedelics in the current regulatory climate, as well as clinical practice doing harm reduction and integration therapy with psychedelics. It is informed by consultation with multiple experts on harm reduction, as well as attorneys knowledgeable about criminal and civil matters relating to drug use and professional practice.
Meet Your Instructors
Jason Luoma, PhD
Jason Luoma, Ph.D. is CEO of Portland Psychotherapy in Portland, OR. His research focuses on shame, self-stigma, connection, and the application of ACT and psychedelic assisted therapy as an intervention shame and increasing self-compassion. He is currently organizing a clinical trial of MDMA-assisted psychotherapy for social anxiety disorder that looks like it may be the first trial of psychedelic assisted therapy in the Pacific Northwest. He also recently organized a special section on psychedelic assisted therapy and contextual behavioral science. He’s an internationally recognized trainer in ACT, former chair of the ACT training committee, and past president of the Association for Contextual Behavioral Science. He has over 60 publications including co-authoring two books: Learning Acceptance and Commitment Therapy and Values in Therapy: A Clinician’s Guide to Helping Clients Explore Values, Increase Psychological Flexibility, and Live a More Meaningful Life. His work on shame and compassion can be read at www.actwithcompassion.com.
Brian Pilecki, Ph.D.
Dr. Brian Pilecki is a clinical psychologist at Portland Psychotherapy that specializes in the treatment of anxiety disorders, trauma and PTSD, and psychedelic-assisted therapy. Brian practices from an orientation based in Acceptance and Commitment Therapy (ACT) and has extensive experience in the areas of mindfulness and meditation that he incorporates into therapy with clients. At Portland Psychotherapy, Brian is an active researcher and a study therapist on several clinical trials including the investigation of the use of MDMA-assisted therapy for the treatment of social anxiety disorder and the use of 5-MeO-DMT for the treatment of treatment-resistant depression. He is a consultant and instructor for Fluence, a leading psychedelic training organization where he is involved in training psilocybin facilitators for Oregon’s new psilocybin services program. Brian is also a co-founder of Portland Integration Network, a network of professionals offering specialized care related to psychedelics in Oregon. He is also the author of the book ACT-Informed Exposure for Anxiety and co-host of Altered States of Context, a podcast about psychotherapy and psychedelics.
The workshop is aimed at health care professionals who are considering or are currently offering psychedelic integration or harm reduction therapy.
After attending this training, participants will be able to:
- Participants will be able to describe the main risks in engaging in psychedelic harm reduction and integration therapy with clients.
- Participants will be able to identify steps that they can take to mitigate such risks in their own clinical practice.
- Participants will be able to list their main reasons for engaging in this type of clinical work, as well as their main concerns.
Registration is online. Presentations will be recorded and sent to anyone who registers for the event.
We reserve a number of partial scholarships for potential attendees who could not otherwise afford to come. We give particular priority given to those who would add diverse and under represented voices to our field. To submit an application, please click here.
Portland Psychology Clinic, Research & Training Center is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Portland Psychotherapy, Clinic, Research & Training Center maintains responsibility for all programs and content.
This workshop grants 2 CE credits for therapists with the purchase of Professionals with CE Certificate ticket and live attendance of the entire workshop. Credit will not be given for only watching the recording.
REFUNDS/CANCELLATIONS: We charge a $15 administration fee for cancellations made by participants more than two weeks before the training event. For cancellations within two weeks of the training event, we will refund 50% of the tuition. Alternately, participants may elect to apply 100% of their tuition to a future training event. No refunds will be given after training events.
SPECIAL ACCOMODATIONS: Please contact us if you need accommodations to enable you to fully participate in the workshop. We will work with you and do our best to find a way to ensure your participation.